D. Prieto-Alhambra

First name
D.
Last name
Prieto-Alhambra
Khalid, S., Calderon-Larranaga, S., Sami, A., Hawley, S., Judge, A., Arden, N., et al. (2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1
View
Swain, S., Coupland, C., Strauss, V., Mallen, C., Kuo, C. F., Sarmanova, A., et al. (2022). Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2021.12.013
View
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Murray, D., Carr, A., Cooper, C., & Arden, N. K. (2011). Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Bmj. http://doi.org/10.1136/bmj.d7222
View
Prieto-Alhambra, D., Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., & Arden, N. K. (2011). Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/ard.2010.131110
View
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., et al. (2011). Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. http://doi.org/10.1002/art.30214
View
Wallace, G., Judge, A., Prieto-Alhambra, D., de Vries, F., Arden, N. K., & Cooper, C. (2014). The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2014.04.013
View
Prieto-Alhambra, D., Javaid, M. K., Judge, A., Maskell, J., Cooper, C., & Arden, N. K. (2015). Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2013-204043
View
Culliford, D., Maskell, J., Judge, A., Cooper, C., Prieto-Alhambra, D., & Arden, N. K. (2015). Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2014.12.022
View
Driessen, J. H., Henry, R. M., van Onzenoort, H. A., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., et al. (2015). Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int. http://doi.org/10.1007/s00223-015-9993-5
View
Judge, A., Wallace, G., Prieto-Alhambra, D., Arden, N. K., & Edwards, C. J. (2015). Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kev268
View